Effects of galanin message-associated peptide and neuropeptide y against various non-albicans Candida strains

International Journal of Antimicrobial Agents

Volumn 38, Issue 1, 2011, Pages 76-80

  Holub, Barbara S ^a   Rauch, Isabella ^a,b   Radner, Simone ^a   Sperl, Wolfgang ^a   Hell, Markus ^a   Kofler, Barbara ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

GMAP; Neuropeptides; Non albicans Candida; NPY

Indexed keywords

GALANIN MESSAGE ASSOCIATED PEPTIDE; NEUROPEPTIDE Y; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; FUNGAL STRAIN; FUNGUS GROWTH; GROWTH INHIBITION; NONHUMAN; PICHIA ANOMALA; PICHIA JADINII; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA; GALANIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; SPECIES SPECIFICITY;

EID: 79958043445     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.02.019     Document Type: Article

References (15)

1. M. Zasloff Innate immunity, antimicrobial peptides, and protection of the oral cavity Lancet 360 2002 1116 1117 (Pubitemid 35246481)
2. K.A. Brogden, J.M. Guthmiller, M. Salzet, and M. Zasloff The nervous system and innate immunity: the neuropeptide connection Nat Immunol 6 2005 558 564 (Pubitemid 41710725)
3. I. Vouldoukis, Y. Shai, P. Nicolas, and A. Mor Broad spectrum antibiotic activity of the skin-PYY FEBS Lett 380 1996 237 240 (Pubitemid 26064760)
4. M. Shimizu, Y. Shigeri, Y. Tatsu, S. Yoshikawa, and N. Yumoto Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation Antimicrob Agents Chemother 42 1998 2745 2746 (Pubitemid 28462926)
5. C.J. Hansen, K.K. Burnell, and K.A. Brogden Antimicrobial activity of substance P and neuropeptide Y against laboratory strains of bacteria and oral microorganisms J Neuroimmunol 177 2006 215 218 (Pubitemid 44108239)
6. I.A. El Karim, G.J. Linden, D.F. Orr, and F.T. Lundy Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites J Neuroimmunol 200 2008 11 16
7. R. Lang, A.L. Gundlach, and B. Kofler The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease Pharmacol Ther 115 2007 177 207 (Pubitemid 47042915)
8. I. Rauch, L. Lundstrom, M. Hell, W. Sperl, and B. Kofler Galanin message-associated peptide suppresses growth and the budded-to-hyphal-form transition of Candida albicans Antimicrob Agents Chemother 51 2007 4167 4170 (Pubitemid 350057821)
9. A.J. Brown, and N.A. Gow Regulatory networks controlling Candida albicans morphogenesis Trends Microbiol 7 1999 333 338 (Pubitemid 29342306)
10. M. Whiteway, and U. Oberholzer Candida morphogenesis and host-pathogen interactions Curr Opin Microbiol 7 2004 350 357 (Pubitemid 39091118)
11. R. Prasad, and K. Kapoor Multidrug resistance in yeast Candida Int Rev Cytol 242 2005 215 248 (Pubitemid 39642964)
12. M.A. Pfaller, M. Castanheira, S.A. Messer, G.J. Moet, and R.N. Jones Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009) Diagn Microbiol Infect Dis 68 2010 278 283
13. R. Fleck, A. Dietz, and H. Hof In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest J Antimicrob Chemother 59 2007 767 771 (Pubitemid 47073416)
14. A.Z. Rodríguez, B. Gómez Cde, C.A. Restrepo, H.H. Parra, M.A. Arteaga, and A.R. Moreno Susceptibility to fluconazole and voriconazole of Candida species isolated from intensive care units patients in Medellin, Colombia (2001-2007) Rev Iberoam Micol 27 2010 125 129 [in Spanish]
15. S. Joly, C. Maze, P.B. McCray Jr., and J.M. Guthmiller Human β-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms J Clin Microbiol 42 2004 1024 1029 (Pubitemid 38332820)